Generate:Biomedicines and Roswell Park join forces on AI-driven cancer therapies
Pharmaceutical Technology - 02-Nov-2023Collaboration aims to develop advanced CAR T-cell treatments for solid tumours
Join the club for FREE to access the whole archive and other member benefits.
Pharma News Publisher
Pharmaceutical-technology.com is one of a network of 40+ proprietary B2B websites, with an unrivalled global audience of active decision makers, influencers, and opinion leaders across the world with a combined readership of 55 million industry professionals each year.
As part of GlobalData, we have access to over 1bn data points including companies, deals, projects and forecasts, and trends. Leading data informs and supports our industry leading content. With expertise spanning more than 80 markets globally and driven by 800+ award-winning journalists, researchers, and analysts, we connect you with the information that makes and breaks businesses every day.
Combined with our award-winning targeting technology built into our network of websites, we offer a unique end-to-end marketing solution combining insight, creativity, and cutting-edge AI-technology. Our marketing solution allows clients to identify, target and engage with prospects using access and ownership of our 40+ B2B media websites and their large sector specific audiences. With more reach, data targeting and first-party data than any other partner, we produce world-class campaigns for our clients.
Visit website: https://www.pharmaceutical-technology.com/
Details last updated 19-Oct-2024
Collaboration aims to develop advanced CAR T-cell treatments for solid tumours
GC will design and deliver mRNA constructs; Immetas will identify therapeutic targets
New funding accelerates clinical trials and expands its pipeline of protein-based therapies